Sleepiness and the reinforcing and subjective effects of methylphenidate

Experimental and Clinical Psychopharmacology

Volumn 7, Issue 2, 1999, Pages 145-150

  Roehrs, Timothy ^a   Papineau, Kate ^a   Rosenthal, Leon ^a   Roth, Thomas ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; PLACEBO;

ADULT; ALERTNESS; ARTICLE; ATTENTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG PREFERENCE; FATIGUE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PERFORMANCE; REINFORCEMENT; SCORING SYSTEM; SLEEP TIME; SOMNOLENCE;

ADULT; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; HUMANS; MALE; METHYLPHENIDATE; PSYCHOMOTOR PERFORMANCE; REINFORCEMENT (PSYCHOLOGY); SLEEP;

EID: 0032965320     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/1064-1297.7.2.145     Document Type: Article

References (37)

1. Bishop, C., Roehrs, T., Rosenthal, L., & Roth, T. (1997). Alerting effects of methylphenidate under basal and sleep-deprived conditions. Experimental and Clinical Psychopharmacology, 5, 344-352.
2. Bornstein, S. K. (1982). Respiratory monitoring during sleep: Polysomnography. In C. Guilleminault (Ed.), Sleeping and waking disorders: Indications and techniques (pp. 183-212). Menlo Park, CA: Addison-Wesley.
3. Butcher, J. N., Dahlstrom, W. G., Graham, J. R., Tellegen, A., & Kaemmer, B. (1989). MMPI-2: Minnesota Multiphasic Personality Inventory - 2: Manual for administration and scoring. Minneapolis, MN: University of Minnesota Press.
4. Carskadon, M. A., Dement, W. C., Miller, M. M., Roth, T., Westbrook, P. R., & Keenan, S. (1986). Guidelines for Multiple Sleep Latency Test (MSLT): A standard measure of sleepiness. Sleep, 9, 519-524.
5. Chait, L. D. (1994). Reinforcing and subjective effects of methylphenidate in humans. Behavioral Pharmacology, 5, 281-288.
6. Clark, C. R., Geffen, G. M., & Geffen, L. B. (1986). Role of monoamine pathways in the control of attention: Effects of droperidol and methylphenidate in normal adult humans. Psychopharmacology, 90, 28-34.
7. Coleman, R. M. (1982). Periodic movements in sleep (nocturnal myoclonus) and restless legs syndrome. In C. Guilleminault (Ed.), Sleeping and waking disorders: Indications and techniques (pp. 265-295). Menlo Park, CA: Addison-Wesley.
8. Comer, S. D., Haney, M., Foltin, R. W., & Fischman, M. W. (1996). Amphetamine self-administration by humans: Modulation by contingencies associated with task performance. Psychopharmacology, 127, 39-46.
9. Cornell University Medical College. (1974). Cornell Medical Index: Health questionnaire. New York: Cornell University Medical College.
10. deWit, H., Uhlenhuth, E. H., & Johanson, C. E. (1985). Drug preference in normal volunteers: Effects of age and time of day. Psychopharmacology, 87, 186-193.
11. deWit, H., Uhlenhuth, E. H., & Johanson, C. (1986). Individual differences in the reinforcing and subjective effects of amphetamine and diazepam. Drug and Alcohol Dependence, 16, 341-360.
12. Drug Abuse Warning Network. (1991). Annual medical examiner data 1990: Data from the Drug Abuse Warning Network (DHHS Publication No. ADM 91-1840). Rockville, MD: National Institute on Drug Abuse.
13. Drug Enforcement Administration. (1995). Methylphenidate yearly production. Washington, DC: U.S. Government Printing Office.
14. Fischman, M. W. (1987). Cocaine and amphetamines. In H. Y. Meltzer (Ed.), Psychopharmacology: The third generation of progress (pp. 1543-1553). New York: Raven Press.
15. Fischman, M. W., & Schuster, C. R. (1980). Cocaine effects in sleep-deprived humans. Psychopharmacology, 72, 1-8.
16. Foltin, R. W., & Fischman, M. W. (1991). Assessment of abuse liability of stimulant drugs in humans: A methodological survey. Drug and Alcohol Dependence, 2, 3-48.
17. Haertzen, C. A. (1974). An overview of the Addiction Research Center Inventory (ARCI): An appendix and manual of scales. Rockville, MD: National Institute on Drug Abuse.
18. Haglund, R. M. J., & Howerton, L. L. (1982). Ritalin: Consequences of abuse in a clinical population. International Journal of Addictions, 17, 349-356.
19. Heishman, S. J., & Henningfield, J. E. (1991). Discriminative stimulus effects of d-amphetamine, methylphenidate, and diazepam in humans. Psychopharmacology, 103, 436-442.
20. Huey, L. Y., Janowsky, D. S., Judd, L. L., Roitman, N. A., Clopton, P. L., Segal, D., Hall, L., & Parker, L. (1980). The effects of naloxone on methylphenidate-induced mood and behavioral changes: A negative study. Psychopharmacology, 67, 125-130.
21. Jaffe, S. L. (1991). Intranasal abuse of prescribed methylphenidate by an alcohol and drug abusing adolescent with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 3, 773-775.
22. Johanson, C. E., & deWit, H. (1989). The use of choice procedures for assessing the reinforcing properties of drugs in humans. In M. Fishman & N. Mello (Eds.), Assessing the abuse liability of drugs in humans (pp. 171-209). Washington, DC: National Institute of Drug Abuse.
23. Lasagna, L., Von Feisinger, J. M., & Beecher, H. K. (1955). Drug-induced mood changes in man. 1. Observations on healthy subjects, chronically ill patients and "postaddicts." Journal of the American Medical Association, 15, 1006-1020.
24. Levine, B., Roehrs, T., Zorick, F., & Roth, T. (1958). Daytime sleepiness in young adults. Sleep, 11, 39-46.
25. Lundquest, D. E., Young, W. K., & Edland, J. (1987). Maternal death associated with intravenous methylphenidate (Ritalin) and pentazocine (Talwin) abuse. Journal of Forensic Science, 32, 798-801.
26. Martin, W. R., Sloan, J. W., S'apira, J. D., & Jasinski, D. L. (1971). Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clinical Pharmacology and Therapeutics, 12, 245-258.
27. McNair, D., Lorr, M., & Droppleman, L. F. (1971). Manual for the Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service.
28. Newhouse, P. A., Belenky, G., Thomas, M., Thorne, D., Sing, H. C., & Fertig, J. (1989). The effects of d-amphetamine on arousal, cognition, and mood after prolonged total sleep deprivation. Neuropsychopharmacology, 2, 153-163.
29. Parran, T. V., Jr., Jasinski, D. R. (1991). Intravenous methylphenidate abuse: Prototype for prescription drug abuse. Archives of Internal Medicine, 151, 781-783.
30. Rechtschaffen, A., & Kales, A. (1968). A manual of standardized techniques and scoring system for sleep stages of human sleep. Los Angeles: Brain Information Service/Brain Research Institute, University of California at Los Angeles.
31. Roehrs, T., Shore, E., Papineau, K., Rosenthal, L., & Roth, T. (1996). A two-week extension in sleepy normals. Sleep, 16, 576-582.
32. Roehrs, T. A., Timms, V., Zwyghuizen-Doorenbos, A., & Roth, T. (1989). Sleep extension in sleepy and alert normals. Sleep, 12, 449-457.
33. Roth, T., Roehrs, T., Carskadon, M., & Dement, W. (1994). Daytime sleepiness and alertness. In M. Kryger, T. Roth, & W. Dement (Eds.), Principles and practice of sleep medicine (2nd ed., pp. 40-49). Philadelphia: Saunders.
34. Rush, C. R., Kollins, S. H., & Pazzaglia, P. J. (1998). Discriminative-stimulus and subject-rated effects of methlyphenidate, bupropion and triazolam in d-amphetamine-trained humans. Experimental and Clinical Psychopharmacology, 6, 32-44.
35. Silverman, K., Kirby, K. C., & Griffiths, R. R. (1994). Modulation of drug reinforcement by behavioral requirements following drug ingestion. Psychopharmacology, 114, 243-247.
36. Uhlenhuth, E. H., Johanson, C. E., Kilgore, K., & Kobasa, S. C. (1981). Drug preference and mood in humans: Preference for d-amphetamine and subject characteristics. Psychopharmacology, 74, 191-194.
37. Volkow, N. D., Ding, Y. S., Fowler, J. S., Wang, G. J., Logan, J., Gatley, J. S., Dewey, S., Ashby, C., Liebermann, J., Hitzemann, R., & Wolf, A. P. (1995). Is methylphenidate like cocaine? Archives of General Psychiatry, 52, 456-463.